Plasma Derived Therapy Market Revenue 2025 to 2034
Plasma Derived Therapy Market Revenue 2025 to 2034
Plasma Derived Therapy Market (By Product: Immunoglobulin, Coagulation factors, Albumin, Others; By Application: Hemophilia, Primary immunodeficiency disease, Idiopathic thrombocytopenic purpura, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 23.39 Bn
Forecast Year, 2034
USD 45.29 Bn
CAGR, 2025 - 2034
6.83%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The plasma-derived therapy market is projected to expand from USD 23.39 billion in 2025 to approximately USD 45.29 billion by 2034, reflecting a robust CAGR of 6.83%. This growth is driven by increasing demand for life-saving treatments and advancements in plasma collection and processing technologies.
Plasma Derived Therapy Market Size Analysis
Plasma Derived Therapy Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunoglobulin | 11.23 | 11.99 | 12.81 | 13.69 | 14.62 | 15.62 | 16.69 | 17.83 | 19.05 | 20.35 |
| Coagulation factors | 5.15 | 5.50 | 5.87 | 6.27 | 6.70 | 7.16 | 7.65 | 8.17 | 8.73 | 9.33 |
| Albumin | 3.74 | 4.00 | 4.27 | 4.56 | 4.87 | 5.21 | 5.56 | 5.94 | 6.35 | 6.78 |
| Others | 3.27 | 3.50 | 3.74 | 3.99 | 4.27 | 4.56 | 4.87 | 5.20 | 5.56 | 5.93 |
Plasma Derived Therapy Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hemophilia | 8.89 | 9.50 | 10.14 | 10.84 | 11.58 | 12.37 | 13.21 | 14.11 | 15.08 | 16.11 |
| Primary immunodeficiency disease | 7.48 | 8.00 | 8.54 | 9.13 | 9.75 | 10.41 | 11.13 | 11.89 | 12.70 | 13.56 |
| Idiopathic thrombocytopenic purpura | 4.21 | 4.50 | 4.80 | 5.13 | 5.48 | 5.86 | 6.26 | 6.69 | 7.14 | 7.63 |
| Others | 2.81 | 3.00 | 3.20 | 3.42 | 3.66 | 3.91 | 4.17 | 4.46 | 4.76 | 5.09 |
Plasma Derived Therapy Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 9.82 | 10.49 | 11.21 | 11.98 | 12.80 | 13.67 | 14.60 | 15.60 | 16.67 | 17.80 |
| Asia Pacific | 5.61 | 6.00 | 6.41 | 6.84 | 7.31 | 7.81 | 8.34 | 8.91 | 9.52 | 10.17 |
| Europe | 4.21 | 4.50 | 4.80 | 5.13 | 5.48 | 5.86 | 6.26 | 6.69 | 7.14 | 7.63 |
| LAMEA | 3.74 | 4.00 | 4.27 | 4.56 | 4.87 | 5.21 | 5.56 | 5.94 | 6.35 | 6.78 |
Plasma Derived Therapy Market Size to Touch USD 45.29 Billion by 2034
The plasma derived therapy market size was evaluated at USD 23.39 billion in 2025 and is expected to grow around USD 45.29 billion by 2034 a CAGR of 6.83%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
